Downstream Processing Featured Articles

  1. New SPE Accessories Hold Tubes In 96-Well Spacing For Automated Applications 8/9/2012

    Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces two new Tabless Tube Holder accessories for its Strata and Strata-X lines of silica-based and polymeric solid phase extraction (SPE) sorbents. 

  2. Horizon Discovery And Boehringer Ingelheim Enter Oncology Research Service Collaboration 1/14/2013

    Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, recently announced it has signed a research service collaboration agreement with Boehringer Ingelheim.

  3. PBS Biotech Launches Single-Use Bioreactor For Development Of New Vaccines And Biosimilars 5/25/2011
    PBS Biotech, Inc., a developer of state of the art bioreactors to be used in the fast growing biotechnology market, announced recently the launch of its innovative PBS 3 single-use bioreactor system.
  4. Pfenex Inc. Awards Althea Technologies A Contract For cGMP Manufacturing Of Circumsporozoite Protein From Plasmodium Falciparum, A Key Malaria Antigen 10/24/2012

    Pfenex Inc. recently announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine.

  5. New Gene Mutations Linked To ALS And Nerve Cell Growth Dysfunction 7/16/2012

    Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis - ALS, also known as Lou Gehrig's disease. 

  6. Unraveling The Molecular Roots Of Down Syndrome 3/24/2013

    What is it about the extra chromosome inherited in Down syndrome—chromosome 21—that alters brain and body development? Researchers have new evidence that points to a protein called sorting nexin 27, or SNX27.

  7. Biologists Engineer Algae To Make Complex Anti-Cancer 'Designer' Drug 12/10/2012

    Biologists at UC San Diego have succeeded in genetically engineering algae to produce a complex and expensive human therapeutic drug used to treat cancer.

  8. FDA Offers New Guidance On Developing Drugs For Alzheimer's Disease 2/7/2013

    Recently, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer’s disease, before the onset of noticeable (overt) dementia.

  9. Researchers' Sequencing Of Human and Monkey Malaria Genomes Reveals Challenges, Opportunities In Battle Against Parasite 8/5/2012

    Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria.

  10. Waters UltraPerformance Convergence Chromatography Ushers In New Category Of Separation Science At Pittcon 3/13/2012
    Waters Corporation recently drew back the curtain on several important new technologies and a new business venture at Pittcon 2012, the industry’s most important annual new product conference and exhibition.